| CCT245737 |
CCT245737 |
1489389-18-5 |
| UNC2250 |
反式-4-[[2-(丁基氨基)-5-[5-(4-吗啉基甲基)-2-吡啶基]-4-嘧啶基]氨基]环己醇 |
1493694-70-4 |
| UNC2881 |
UNC2881 |
1493764-08-1 |
| ZA7371 |
N-(2-羟基乙基)-1-[(6-甲氧基-5-甲基嘧啶-4-基)甲基]-6-甲基-1H-吡咯并[3,2-B]吡啶-3-甲酰胺 |
1494675-86-3 |
| GNE-3511 |
化合物GNE-3511 |
1496581-76-0 |
| 2-[8-Chloro-6-(4-chloro-phenyl)-1-Methyl-4H-3-oxa-2,5-diaza-benzo[e]azulen-4-yl]-acetaMide |
化合物BET BROMODOMAIN INHIBITOR |
1505453-59-7 |
| EGF816 |
EGF816 |
1508250-71-2 |
| K-Ras inhibitor |
6H05 (6H零5) |
1469338-01-9 |
| 1-(4-(2-((4-chloro-2-hydroxy-5-iodophenyl)aMino)acetyl)piperazin-1-yl)prop-2-en-1-one |
K-RAS(G12C) INHIBITOR 12 |
1469337-95-8 |
| Atglistatin |
ATGLISTATIN |
1469924-27-3 |
| KRCA-0008 |
1,1'-((((5-氯嘧啶-2,4-二基)双(氮烷二基))双(3-甲氧基-4,1-亚苯基))双(哌嗪-4,1-二基))双(乙-1-酮) |
1472795-20-2 |
| 7ACC-2 |
7ACC-2 |
1472624-85-3 |
| N-(4-ethylphenyl)-3-(hydroxymethyl)-N-isobutyl-4-((tetrahydro-2H-pyran-4-yl)methoxy)benzenesulfonamide |
GSK2981278 |
1474110-21-8 |
| Nrf1-activator-1 |
NRF1-ACTIVATOR-1 |
1474034-05-3 |
| CAY10683 (SantacruzaMate A) |
HDAC抑制剂 |
1477949-42-0 |
| UNC-0642 |
2-(4,4-二氟-1-哌啶基)-6-甲氧基-N-[1-异丙基-4-哌啶基]-7-[3-(1-吡咯烷基)丙氧基]-4-喹唑啉胺 |
1481677-78-4 |
| HUHS015 |
HUHS015 |
1453097-13-6 |
| GDC-0994 |
GDC-0994 |
1453848-26-4 |
| PU-WS13 |
6-氨基-8-[(3,5-二氯苯基)硫基]-N-异丙基-9H-嘌呤-9-丙胺 |
1454619-14-7 |
| N-((4,5-difluoro-1H-benzo[d]imidazol-2-yl)methyl)-9-(3-fluorophenyl)-2-morpholino-9H-purin-6-amine |
SR-3029 |
1454585-06-8 |
